Research Reports Treasure Hunting丨GTJA: Maintain BEIGENE's "Shareholding" rating, expecting to turn around losses in 2025.

Gelonghui on January 22 | GTJA Research Reports pointed out that BEIGENE (6160.HK) is experiencing rapid growth in the sales of zebrutinib, and it is expected to reach a breakeven point in 2025. In the first three quarters of 2023, sales revenue from zebrutinib totaled 1.82 billion USD, an increase of 107% year-on-year, with a market share in newly diagnosed CLL patients exceeding that of competitors ibrutinib and acalbrutinib, ranking first. This trend is expected to maintain rapid growth as the patient base continues to accumulate. In 2025, the company is expected to achieve breakeven in GAAP Operation profit. Additionally, several self-developed products are entering a period of intensive harvesting. Considering the company's core products in

Gelonghui FinanceJan 22 15:33 · Ratings

BEIGENE (06160) JPM 2025 releases Bullish news, multiple international investment banks remain Bullish on the company's prospects.

At the JPM Conference in 2025, BEIGENE management clearly provided guidance on the timeline for profitability, expecting to achieve GAAP operating profit break-even in 2025, one year earlier than market expectations.

Zhitong FinanceJan 21 10:34

BeiGene, Ltd.'s (NASDAQ:ONC) Profit Outlook

Simply Wall StJan 21 01:43

BeiGene Enters Sublease Agreement With ChemoCentryx for Expansion

TipRanksJan 20 18:40

BEIGENE (06160.HK) subsidiary signs a sublease agreement with Chemo Centryx.

On January 20, Gelonghui announced that BEIGENE (06160.HK) signed a sublease agreement on January 17, 2025 (USA time) between a wholly-owned subsidiary BEIGENE US (as lessee) and Chemo Centryx (as sublessor), whereby Chemo Centryx agreed to sublease the property to BEIGENE US. The lease term shall commence from the effective date of the sublease until the expiration date of the sublease. Subleased property: Approximately 96,372 square feet of rentable space, including about 49,820 square feet on the fifth floor and the sixth floor.

Gelonghui FinanceJan 20 18:23

BeiGene Announces Board Composition and Committee Roles

TipRanksJan 20 17:07